中国组织工程研究 ›› 2024, Vol. 28 ›› Issue (7): 1036-1042.doi: 10.12307/2024.127

• 干细胞基础实验 basic experiments of stem cells • 上一篇    下一篇

利鲁唑干预脊髓损伤大鼠小胶质细胞中NLRP3炎性小体的活化

刘  涛,张文凯,马子谦,张  焱,陈学明   

  1. 首都医科大学附属北京潞河医院骨中心,北京市   101100
  • 收稿日期:2023-01-18 接受日期:2023-04-08 出版日期:2024-03-08 发布日期:2023-07-15
  • 通讯作者: 陈学明,博士,主任医师,副教授,首都医科大学附属北京潞河医院骨中心,北京市 101100
  • 作者简介:刘涛,男,1997年生,山东省泰安市人,汉族,首都医科大学在读硕士,主要从事颈腰椎退变性疾病与脊柱脊髓损伤方面的研究。 张文凯,男,1996年生,河南省商丘市人,汉族,首都医科大学毕业,硕士,主要从事颈腰椎退变性疾病与脊柱脊髓损伤方面的研究。
  • 基金资助:
    北京市通州区高层次发展人才发展支持计划-顶尖人才(YHDJ2019007),项目负责人:陈学明

Riluzole interferes with the activation of NLRP3 inflammasome in microglia of rats with spinal cord injury

Liu Tao, Zhang Wenkai, Ma Ziqian, Zhang Yan, Chen Xueming   

  1. Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China
  • Received:2023-01-18 Accepted:2023-04-08 Online:2024-03-08 Published:2023-07-15
  • Contact: Chen Xueming, MD, Chief physician, Associate professor, Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China
  • About author:Liu Tao, Master candidate, Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China Zhang Wenkai, Master, Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China
  • Supported by:
    Beijing Tongzhou District High-Level Talents Development Support Program - Leading Top Talents, No. YHDJ2019007 (to CXM)

摘要:


文题释义:

NLRP3:即核苷酸结合寡聚化结构域样受体蛋白3,是一种目前被研究最多的炎性小体,可在脊髓损伤后迅速激活,启动一系列级联反应,加重神经炎症。
利鲁唑:是一种具有神经保护作用的苯噻唑类化合物,1995年被美国食品药品监督管理局(FDA)批准用于治疗肌肉萎缩性侧索硬化症。已有研究表明其可减轻脊髓损伤后的炎症反应。


背景:既往动物实验研究发现利鲁唑可抑制脊髓损伤后神经炎症反应,促进损伤大鼠功能恢复,但其是否可在急性期调控核苷酸结合寡聚化结构域样受体蛋白3(nucleotide-binding oligomerization domain-like receptor protein 3,NLRP3)炎性小体的表达缺乏研究。

目的:通过动物实验、组织学实验、分子生物学实验观察利鲁唑是否通过调控NLRP3炎性小体减轻脊髓损伤后小胶质细胞焦亡,促进功能恢复。
方法:将雌性SD大鼠分为假手术组、模型组、利鲁唑组,每组12只。除假手术组外行大鼠T10脊髓损伤,模型组腹腔给药利鲁唑的溶剂环糊精,利鲁唑组注射4 mg/kg利鲁唑治疗。采用BBB评分、斜板实验评估利鲁唑对运动功能恢复的影响;电生理检测感觉诱发电位和运动诱发电位的恢复情况;苏木精-伊红染色评估脊髓组织修复情况;Western blot方法检测利鲁唑对脊髓组织中NLRP3、半胱氨酸蛋白酶1、消皮素D蛋白表达的调控作用;ELISA检测炎症因子白细胞介素1β、白细胞介素18表达水平;免疫荧光染色检测利鲁唑对脊髓损伤组织中小胶质细胞中NLRP3、半胱氨酸蛋白酶1、消皮素D、白细胞介素1β表达的影响。

结果与结论:①脊髓损伤后35 d,利鲁唑组大鼠BBB评分和斜板实验评分均高于模型组(P < 0.05);②脊髓损伤后3 d,利鲁唑组脊髓组织匀浆中NLRP3、活化半胱氨酸蛋白酶1、消皮素D氨基端蛋白、白细胞介素1β、白细胞介素18蛋白表达明显低于模型组(P < 0.05);③脊髓损伤后3 d,免疫荧光实验显示利鲁唑组NLRP3、半胱氨酸蛋白酶1、消皮素D、白细胞介素1β荧光强度明显低于模型组(P < 0.05);④脊髓损伤后35 d,苏木精-伊红染色显示利鲁唑组脊髓损伤面积比模型组更小;电生理检测显示利鲁唑组感觉诱发电位与运动诱发电位潜伏期均较模型组缩短,波幅较模型组提高;⑤以上结果可表明,利鲁唑促进损伤脊髓组织、神经传导功能修复进而促进脊髓损伤大鼠运动功能恢复,可能是通过调控NLRP3炎性小体、减轻小胶质细胞焦亡实现的。

https://orcid.org/0009-0006-5688-5946 (刘涛) 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 利鲁唑, 脊髓损伤, NLRP3, 小胶质细胞, 焦亡

Abstract: BACKGROUND: Previous animal studies have shown that riluzole can inhibit neuroinflammatory response after spinal cord injury and promote functional recovery in injured rats, but the study on whether it can regulate the expression of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in the acute stage is lacking. 
OBJECTIVE: To observe whether riluzole can reduce microglial pyroptosis and promote functional recovery after spinal cord injury by modulating NLRP3 inflammasome through animal experiments, histological experiments and molecular biology experiments.
METHODS: Female SD rats were divided into sham operation, model and riluzole groups, with 12 rats in each group. In addition to the sham operation group, T10 spinal cord injury was conducted in rats. The model group was treated with intraperitoneal administration of riluzole with solvent cyclodextrin. The riluzole group was treated with a 4 mg/kg dose of riluzole injection. The effect of riluzole on motor function recovery was assessed using the BBB score and inclined plane test. The recovery of sensory-evoked potential and motor-evoked potential was measured by electrophysiology. Hematoxylin-eosin staining was used to evaluate spinal cord tissue repair. The regulatory effects of riluzole on NLRP3, Caspase-1 and gasdermin D protein expression in spinal cord tissues were detected by western blot assay. ELISA was utilized to detect the expression levels of inflammatory factors interleukin-1β and interleukin-18. The effects of riluzole on the expression of NLRP3, Caspase-1, gasdermin D and interleukin-1β in microglial cells of the injured spinal cord were determined by immunofluorescence staining. 
RESULTS AND CONCLUSION: (1) At 35 days after spinal cord injury, BBB score and inclined plane test score in the riluzole group were higher than those in the model group (P < 0.05). (2) At 3 days after spinal cord injury, the protein expressions of NLRP3, cleaved Caspase-1, gasdermin D-N (N-terminal domain), interleukin-1β, and interleukin-18 in the spinal cord homogenate of the riluzole group were significantly lower than those of the model group (P < 0.05). (3) At 3 days after spinal cord injury, the fluorescence intensity of NLRP3, Caspase-1, gasdermin D and interleukin-1β in the riluzole group was significantly lower than that in the model group (P < 0.05). (4) At day 35 after spinal cord injury, hematoxylin-eosin staining showed that the area of spinal cord injury in the riluzole group was smaller than that in the model group. Electrophysiological tests showed that the latency periods of sensory-evoked potential and motor-evoked potential in the riluzole group were shorter than those in the model group, and the latency period of wave amplitude in the riluzole group was higher than that in the model group. (5) These results suggest that riluzole can promote the repair of injured spinal cord tissue, promote the repair of nerve conduction function, and further promote the recovery of motor function in rats with spinal cord injury, which may be achieved through the regulation of NLRP3 inflammasome and the reduction of microglial pyroptosis. 

Key words: riluzole, spinal cord injury, NLRP3, microglia, pyroptosis

中图分类号: